INCREMENTAL MEDICAID EXPENDITURES ASSOCIATED WITH DEMENTIA

Author(s)

Ankita Modi, BPharm, MS, PhD Student1, Murtuza Bharmal, BPharm, MS, PhD, Senior Manager2, Seema Dedhiya, BPharm, MS, PhD, Researcher1, Bruce Craig, MS, PhD, Associate Professor1, Michael Weiner, MD, MPH, Associate Professor of Medicine3, Marc Rosenman, MD, Assistant Professor4, Laura Sands, MS, PhD, Associate Professor and Director of Faculty Development5, Joseph Thomas III, MS, PhD, Professor61Purdue University, West Lafayette, IN, USA; 2 Quintiles Transnational Corporation, Falls Church, VA, USA; 3 Indiana University, Indiana University Center for Aging Research and Regenstrief Institute Inc, Indianapolis, IN, USA; 4 Indiana University and Regenstrief Institute Inc, Indianapolis, IN, USA; 5 Purdue University and Regenstrief Center for Healthcare Engineering, West Lafayette, IN, USA; 6 Purdue University and Regenstrief center for Healthcare Engineering, West Lafayette, IN, USA

OBJECTIVES: This study determined incremental Medicaid expenditures associated with dementia among Indiana Medicaid recipients in 2004. METHODS: Analysis of Indiana Medicaid claims and enrollment files was conducted. Sample inclusion criteria were being at least 40 years old and having Indiana Medicaid eligibility in 2004. Twenty-six ICD-9 diagnosis codes determined in a prior study to be specific for dementia were used to identify dementia. Regression models were developed to estimate incremental expenditures in U.S. dollars. Assessment of model fit was used to select from OLS regression, OLS on log of response variables, generalized linear negative binominal, and zero-inflated negative binomial models. Based on fit and Voung statistics, zero-inflated negative binomial regression was used to fit separate models for total expenditures and expenditure subcategories. Models included covariates for age, gender, race, marital status, geographic region, months of Medicaid eligibility, months of spend-down in effect, months of Medicare coverage, mortality, and Charlson comorbidity index score. RESULTS: A total of 145,684 individuals meeting inclusion criteria were identified, 18,950 (13%) had dementia. Individuals with dementia had more comorbidity, were older, and were more likely to be female, white, unmarried, and to die during the study period. After adjusting for covariates, Indiana Medicaid spent, mean (standard error), $9,829 (211) p<0.001, more per recipient with dementia in incremental expenditures associated with the disease. Much of the incremental expenditures were due to nursing home expenditures $9,154 (141) p<0.001. Drug expenditures accounted for the second largest component of the incremental expenditures $970 (37) p<0.001, followed by inpatient expenditures $211 (23) p<0.001 and other medical expenditures $128 (57) p<0.05. Dementia was associated with lower outpatient expenditures $-78 (2.50) p<0.001. CONCLUSION: Incremental Medicaid expenditures associated with dementia were substantial even after adjusting for other risk factors and accounted for $186 million or 8% of 2004 Indiana Medicaid expenditures.

Conference/Value in Health Info

2007-05, ISPOR 2007, Arlington, VA, USA

Value in Health, Vol. 10, No.3 (May/June 2007)

Code

PMH18

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Mental Health, Neurological Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×